Standing Committee on Vaccination issues a recommendation for the approval of the protein-based Novavax COVID-19 vaccine for use in adults
The Standing Committee on Vaccination issues a recommendation for the approval of the protein-based Novavax COVID-19 vaccine for use in adults.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthStanding Committee on Vaccination issues a recommendation for the approval of the protein-based Novavax COVID-19 vaccine for use in adults
View Premium plansBrowse free archive reportsThe Standing Committee on Vaccination issues a recommendation for the approval of the protein-based Novavax COVID-19 vaccine for use in adults.